rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-9-15
|
pubmed:abstractText |
Antiphospholipid syndrome (APS) in pregnancy is characterized by the presence of maternal autoantibodies in association with recurrent fetal loss and severe obstetric complications such as prematurity, intrauterine growth retardation, or placental insufficiency. This study aimed to assess the perinatal outcomes in neonates born to mothers with APS.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1875-9572
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
143-6
|
pubmed:meshHeading |
pubmed-meshheading:19750887-Abortion, Spontaneous,
pubmed-meshheading:19750887-Adult,
pubmed-meshheading:19750887-Antiphospholipid Syndrome,
pubmed-meshheading:19750887-Female,
pubmed-meshheading:19750887-Fetal Death,
pubmed-meshheading:19750887-Humans,
pubmed-meshheading:19750887-Infant, Newborn,
pubmed-meshheading:19750887-Infant, Newborn, Diseases,
pubmed-meshheading:19750887-Pregnancy,
pubmed-meshheading:19750887-Pregnancy Complications,
pubmed-meshheading:19750887-Pregnancy Outcome,
pubmed-meshheading:19750887-Thrombocytopenia
|
pubmed:year |
2009
|
pubmed:articleTitle |
Neonatal and pregnancy outcome in primary antiphospholipid syndrome: a 10-year experience in one medical center.
|
pubmed:affiliation |
Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article
|